Oak Grove Capital’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.1M Sell
34,040
-5,010
-13% -$1.61M 0.55% 36
2026
Q2
$18.9M Sell
39,050
-50,000
-56% -$13.3M 0.9% 26
2026
Q1
$9.76M Buy
89,050
+7,850
+10% +$1.12M 0.83% 25
2025
Q4
$13.5M Sell
81,200
-5,700
-7% -$954K 1.6% 16
2025
Q3
$17M Sell
86,900
-6,600
-7% -$1.09M 2.41% 12
2025
Q2
$8.45M Buy
+93,500
New +$7.39M 1.39% 20

Other funds holding ALAB

Oak Grove Capital's ALAB Position: Q3 2026 in Review

Oak Grove Capital reduced its Astera Labs (ALAB) stake by 13% in Q3 2026, selling an estimated $1.61M and leaving 34,040 shares worth $12.1M. The position accounts for 0.55% of the portfolio, ranked #36.

Oak Grove Capital first reported a position in ALAB in Q2 2025 and has held it in 6 quarters since. The position peaked at $18.9M in Q2 2026. 27 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

  • Oak Grove Capital held 34,040 shares of Astera Labs worth $12.1M as of Q3 2026.
  • Oak Grove Capital sold 5,010 Astera Labs shares in Q3 2026, an estimated $1.61M.
  • Astera Labs made up 0.55% of Oak Grove Capital's portfolio in Q3 2026, its #36 holding.
  • Oak Grove Capital first reported a position in Astera Labs in Q2 2025 and has held it in 6 quarters since.
  • Oak Grove Capital's Astera Labs position peaked at $18.9M in Q2 2026.
  • 27 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on Oak Grove Capital's 13F filing for Q3 2026, filed 9 Oct 2026.